Literature DB >> 2376397

Prognostic factors in anal squamous carcinoma: a multivariate analysis of clinical, pathological and flow cytometric parameters in 235 cases.

N A Shepherd1, J H Scholefield, S B Love, J England, J M Northover.   

Abstract

Clinical, pathological and flow cytometric parameters have been analysed by univariate and multivariate analysis to define those parameters of important prognostic influence in 235 cases of surgically treated squamous carcinoma of the anus and perianal skin. Patients had been treated by anorectal excision (166 patients) or by local excision (69). Analyses were carried out on five data sets--the two surgical subgroups, two groups distinguished by site of tumour and on all 235 patients. Univariate analysis showed many parameters to be of prognostic influence, although histological typing of tumours into the more common histological subtypes was of no prognostic value. Parameters of independent prognostic significance in multivariate analysis were those indicating depth of spread, inguinal lymph node involvement and DNA-ploidy. In this study the subdivision of the rarer types of anal canal tumour, such as mucoepidermoid carcinoma, microcystic squamous carcinoma and small cell anaplastic carcinoma, was relevant confirming that these tumours have a poor prognosis. It is now felt that surgery should not be employed as primary treatment in most cases of anal cancer and the results of this study have to be interpreted with caution when applied to patients treated with radiotherapy with or without chemotherapy. Nevertheless, our findings suggest that the most useful prognostic information can be gleaned from accurate clinical staging and an assessment of DNA-ploidy status.

Entities:  

Mesh:

Year:  1990        PMID: 2376397     DOI: 10.1111/j.1365-2559.1990.tb01159.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  7 in total

Review 1.  New approach to anal cancer: individualized therapy based on sentinel lymph node biopsy.

Authors:  Paola De Nardi; Michele Carvello; Carlo Staudacher
Journal:  World J Gastroenterol       Date:  2012-11-28       Impact factor: 5.742

2.  Recurrent squamous cell carcinoma of the anal canal. Predictors of initial treatment failure and results of salvage therapy.

Authors:  W E Longo; A M Vernava; T P Wade; M A Coplin; K S Virgo; F E Johnson
Journal:  Ann Surg       Date:  1994-07       Impact factor: 12.969

3.  Mucoepidermoid carcinoma of the anal canal: A case report and review of the literature.

Authors:  Manabu Yamamoto; Keiji Hirata; Masazumi Tuneyoshi; Yoshihiro Yoshida; Hiromitsu Matsuda; Tomonobu Gion; Yohei Tominaga
Journal:  Mol Clin Oncol       Date:  2018-09-03

4.  Prognostic factors for squamous cell cancer of the anal canal.

Authors:  Prajnan Das; Christopher H Crane; Cathy Eng; Jaffer A Ajani
Journal:  Gastrointest Cancer Res       Date:  2008-01

5.  Metastatic squamous cell carcinoma of the anus: time for a shift in the treatment paradigm?

Authors:  Alice Dewdney; Sheela Rao
Journal:  ISRN Oncol       Date:  2012-05-06

6.  Local tumor control and toxicity in HIV-associated anal carcinoma treated with radiotherapy in the era of antiretroviral therapy.

Authors:  Christoph Oehler-Jänne; Burkhardt Seifert; Urs M Lütolf; I Frank Ciernik
Journal:  Radiat Oncol       Date:  2006-08-18       Impact factor: 3.481

Review 7.  Background and Current Treatment of Squamous Cell Carcinoma of the Anus.

Authors:  Rob Glynne-Jones; Waqar Saleem; Mark Harrison; Suzy Mawdsley; Marcia Hall
Journal:  Oncol Ther       Date:  2016-08-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.